Shortly after food intake, the human body releases a hormone called glucagon-like peptide-1
By February 2025 for semaglutide and March 2025 for tirzepatide, FDA declared both shortages resolved and transitional exemption windows ended
Strategy 17: Weekly Energy Management Schedule Putting everything together into a weekly schedule helps translate strategies into consistent action
New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions Issues like pancreatitis, stomach paralysis higher among patients using GLP-1 inhibitor medications Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday
Patients should not attempt to stop either medication abruptly without medical guidance, as phentermine cessation can cause fatigue and mood changes, while sudden semaglutide discontinuation may trigger rebound appetite and rapid weight regain
Why the dose schedule cannot be rushed Clinical trial data from the phase 2 NEJM study revealed something critical about dose scheduling